DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Loratadine Redidose is a drug marketed by Sun Pharm Inds Ltd and is included in one NDA.
The generic ingredient in LORATADINE REDIDOSE is loratadine. There are thirty-nine drug master file entries for this compound. One hundred and nineteen suppliers are listed for this compound. Additional details are available on the loratadine profile page.
A generic version of LORATADINE REDIDOSE was approved as loratadine by PLD ACQUISITIONS LLC on January 21st, 2003.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Sun Pharm Inds Ltd||LORATADINE REDIDOSE||loratadine||TABLET, ORALLY DISINTEGRATING;ORAL||077153-001||Apr 11, 2007||OTC||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|